How Could Antibiotics, Probiotics, and Corticoids Modify Microbiota and Its Influence in Cancer Immune Checkpoint Inhibitors: A Review
- 16 August 2021
- journal article
- review article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 89 (9)
- https://doi.org/10.1128/iai.00665-20
Abstract
Immunotherapy has become a new paradigm in oncology, improving outcomes for several types of cancer. However, there are some aspects about its management that remain uncertain.This publication has 45 references indexed in Scilit:
- Antibiotic Use Does Not Appear to Influence Response to NivolumabAnticancer Research, 2017
- Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumabAnnals of Oncology, 2017
- Mining the Human Gut Microbiota for Immunomodulatory OrganismsCell, 2017
- Microbiote intestinal et réponses aux thérapies anti-tumoralesmédecine/sciences, 2016
- Leaky gut – concept or clinical entity?Current Opinion in Gastroenterology, 2016
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitisNature Communications, 2016
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaScience, 2015
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacyScience, 2015
- Using Corticosteroids to Reshape the Gut MicrobiomeInflammatory Bowel Diseases, 2015
- Neoantigens in cancer immunotherapyScience, 2015